Thorium induced cytoproliferative effect in human liver cell HepG2: Role of insulin-like growth factor 1 receptor and downstream signaling

被引：20

作者：

Ali, Manjoor ^{[1
]}

Kumar, Amit ^{[1
]}

Pandey, Badri N. ^{[1
]}

机构：

[1] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India

来源：

CHEMICO-BIOLOGICAL INTERACTIONS | 2014年 / 211卷

关键词：

Cytoproliferative effect; Thorium; IGF-1R; Akt and MAPK; Cyclin-E; MITOCHONDRIA; TOXICITY; TH-232;

D O I：

10.1016/j.cbi.2014.01.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Thorium-232 (Th-232), a naturally-occurring actinide has gained significant attention due to its immense potential as a nuclear fuel for advanced reactors. Understanding the biological effects of Th-232 would significantly impact its efficient utilization with adequate health protection. Humans administered with Th-232 (thorotrast patients) or experimental animal models showed that liver is one of the major sites of Th-232 accumulation. Present study reports cellular effects of Th-232-nitrate in a human-derived liver cell (HepG2). Results showed that the low concentration of Th-232 (0.1-10 I'M) induced proliferation of HepG2 cells which was inhibited by the pre-treatment of cells with neutralizing antibody against insulin-like growth factor I receptor (IGF-1R). Consistently, Th-232 treatment was found to increase the phosphorylated level of IGF-1R-associated molecule, IRSI which serves to activate PI3K and MAPK signaling pathways. Pre-treatment with specific inhibitors of PI3K (LY294002) or JNK-MAPK (SP600125) significantly abrogated the cytoproliferative effect of Th-232. Immunofluorescence analysis showed increased levels of phospho-Akt and phospho-p1K, downstream kinases of IGF-1R, in Th-232-treated HepG2 cells suggesting the role of IGF-IR-mediated signaling in Th-232-stimulated cell proliferation. The cell cycle analysis showed that Th-232 increased S and G2-M cell fractions concomitant to the increase of cyclin-E level. Thus, the present investigation highlights the role of IGF-IR-mediated signaling in the cytoproliferative effect of Th-232 in human liver cells at low concentration. (c) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：29 / 35

页数：7

共 50 条

[41] miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor [J].

Guo, Jinling ;

Xia, Bairong ;

Meng, Fanling ;

Lou, Ge .

TUMOR BIOLOGY, 2014, 35 (02) :1557-1564

[42] SUMO-modified insulin-like growth factor 1 receptor (IGF-1R) increases cell cycle progression and cell proliferation [J].

Lin, Yingbo ;

Liu, Hongyu ;

Waraky, Ahmed ;

Haglund, Felix ;

Agarwal, Prasoon ;

Jernberg-Wiklund, Helena ;

Warsito, Dudi ;

Larsson, Olle .

JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (10) :2722-2730

[43] Involvement of Insulin-Like Growth Factor 1 Receptor Signaling in the Amyloid-β Peptide Oligomers-Induced p75 Neurotrophin Receptor Protein Expression in Mouse Hippocampus [J].

Ito, Shingo ;

Menard, Michel ;

Atkinson, Trevor ;

Gaudet, Chantal ;

Brown, Leslie ;

Whitfield, James ;

Chakravarthy, Balu .

JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) :493-506

[44] The putative role of fibroblasts in the pathogenesis of Graves' disease: Evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation [J].

Smith, TJ .

AUTOIMMUNITY, 2003, 36 (6-7) :409-415

[45] Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells [J].

D Chiron ;

S Maïga ;

S Surget ;

G Descamps ;

P Gomez-Bougie ;

S Traore ;

N Robillard ;

P Moreau ;

S Le Gouill ;

R Bataille ;

M Amiot ;

C Pellat-Deceunynck .

Blood Cancer Journal, 2013, 3 :e120-e120

[46] Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells [J].

Chiron, D. ;

Maiga, S. ;

Surget, S. ;

Descamps, G. ;

Gomez-Bougie, P. ;

Traore, S. ;

Robillard, N. ;

Moreau, P. ;

Le Gouill, S. ;

Bataille, R. ;

Amiot, M. ;

Pellat-Deceunynck, C. .

BLOOD CANCER JOURNAL, 2013, 3 :e120-e120

[47] Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells [J].

Liu, Rujiao ;

Tang, Wenbo ;

Han, Xiaotian ;

Geng, Ruixuan ;

Wang, Chenchen ;

Zhang, Zhe .

ONCOLOGY LETTERS, 2018, 16 (05) :5983-5991

[48] Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway [J].

Wu, Yu-ting ;

Bi, Yi-Ming ;

Tan, Zhang-Bin ;

Xie, Ling-Peng ;

Xu, Hong-Lin ;

Fan, Hui-Jie ;

Chen, Hong-Mei ;

Li, Jun ;

Liu, Bin ;

Zhou, Ying-Chun .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 853 :93-102

[49] Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor:: potential mechanistic involvement of Mdm2 and β-arrestin1 [J].

Vasilcanu, R. ;

Vasilcanu, D. ;

Rosengren, L. ;

Natalishvili, N. ;

Sehat, B. ;

Yin, S. ;

Girnita, A. ;

Axelson, M. ;

Girnita, L. ;

Larsson, O. .

ONCOGENE, 2008, 27 (11) :1629-1638

[50] Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1 [J].

R Vasilcanu ;

D Vasilcanu ;

L Rosengren ;

N Natalishvili ;

B Sehat ;

S Yin ;

A Girnita ;

M Axelson ;

L Girnita ;

O Larsson .

Oncogene, 2008, 27 :1629-1638

← 1 2 3 4 5 →